LESLIE BURNSIDE: Open Payments
NPI 1760451454 · CHUBBUCK, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 24 payments from 13 companies in 2025. Trend: 2023 $1,030 · 2024 $807 · 2025 $680
Food & beverage: $500Education: $180
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $163 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $100 |
| ABBVIE INC. | 4 | $96 |
| Janssen Biotech, Inc. | 2 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Arcutis Biotherapeutics, Inc. | 2 | $28 |
| LEO Pharma Inc. | 1 | $24 |
| Organon LLC | 3 | $22 |
| Biofrontera Inc. | 1 | $20 |
Products named: Bimzelx, TREMFYA, SKYRIZI, SPEVIGO, DUPIXENT, Zoryve, ADBRY, AMELUZ.
Industry payments across ID — which companies pay providers there.
